Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age

Marten O, Greiner W (2022)
Health Economics Review 12(1): 28.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 669.60 KB
Abstract / Bemerkung
**Background**
There is evidence to suggest that the proportion of missing values is slightly higher in the older population resulting in lower completion rates of the EQ-5D. However, existing studies rarely provide a within-sample comparison of feasibility properties across age groups to quantify this difference. Hence, this study examines feasibility properties of the EQ-5D-3L and 5L in the general population and explores the impact of age on the completion of EQ-5D instruments. **Methods**
We pool five waves from the English GP Patient Survey, where respondents self-report their health in either EQ-5D-3L or 5L. Descriptive analysis was undertaken to analyse the distribution and proportion of missing values and completion rates stratified by age and EQ-5D version; logistic regression models were specified to quantify the impact of age, gender and potential long-term conditions on the completion of each of the EQ-5D instruments. **Results**
The total sample comprises ~ 4.36 million observations, of which 2.88 million respondents report their health in 5L and 1.47 million in 3L, respectively. Respondents over 64 years have slightly more missing values in each dimension than younger respondents. The highest share was observed for the oldest age group in the dimension anxiety/depression (3L 9.1% vs. 5L 7.6%), but was otherwise below 5%. Consequently, completion rates (observed and predicted) decreased with older age and at a higher rate after the age of 64; this was more pronounced for the 3L. **Conclusion**
Evidence from our study suggests that both the EQ-5D-3L and 5L have good feasibility properties. In comparison to younger populations there appears to be a higher proportion of respondents with incomplete responses beyond the age of 64 years. Overall, the 5L version compares more favourably in terms of missing values, completion rates as well as with regard to the expected probability of an incomplete descriptive system.
Erscheinungsjahr
2022
Zeitschriftentitel
Health Economics Review
Band
12
Ausgabe
1
Art.-Nr.
28
eISSN
2191-1991
Page URI
https://pub.uni-bielefeld.de/record/2963167

Zitieren

Marten O, Greiner W. Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age. Health Economics Review. 2022;12(1): 28.
Marten, O., & Greiner, W. (2022). Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age. Health Economics Review, 12(1), 28. https://doi.org/10.1186/s13561-022-00374-y
Marten, Ole, and Greiner, Wolfgang. 2022. “Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age”. Health Economics Review 12 (1): 28.
Marten, O., and Greiner, W. (2022). Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age. Health Economics Review 12:28.
Marten, O., & Greiner, W., 2022. Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age. Health Economics Review, 12(1): 28.
O. Marten and W. Greiner, “Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age”, Health Economics Review, vol. 12, 2022, : 28.
Marten, O., Greiner, W.: Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age. Health Economics Review. 12, : 28 (2022).
Marten, Ole, and Greiner, Wolfgang. “Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age”. Health Economics Review 12.1 (2022): 28.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2022-10-26T08:50:49Z
MD5 Prüfsumme
829c515876b7aead9c236fdbac441703


Link(s) zu Volltext(en)
Access Level
OA Open Access

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 35593942
PubMed | Europe PMC

Suchen in

Google Scholar